ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

VVY Vivoryon Therapeut

0,80
-0,02 (-2,44%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vivoryon Therapeut VVY Euronext Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,02 -2,44% 0,80 17:40:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,826 0,794 0,85 0,80 0,82
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202407:00GLOBEVivoryon Therapeutics N.V. Reports Full Year 2023 Financial..
16/4/202407:00GLOBEVivoryon Therapeutics N.V. to Report Full Year 2023..
15/3/202407:00GLOBEVivoryon Therapeutics N.V. Announces Changes to Board..
04/3/202407:00GLOBEVivoryon Therapeutics N.V. Provides Update on VIVIAD Phase..
08/1/202407:00GLOBEVivoryon Therapeutics N.V. to Host Investor Meetings in..
06/12/202307:00GLOBEVivoryon Therapeutics N.V. Reports Third Quarter 2023..
28/11/202307:00GLOBEVivoryon Therapeutics N.V. to Report Q3 2023 Financial..
07/11/202307:00GLOBEVivoryon Therapeutics N.V. to Present at Upcoming Investor..
26/10/202307:00GLOBEVivoryon Therapeutics N.V. Provides Comprehensive Progress..
23/10/202307:00GLOBEVivoryon Therapeutics N.V. Reports Positive Outcome from..
17/10/202315:32GLOBEVivoryon Therapeutics N.V. Shares Highlights from Virtual..
05/10/202307:00GLOBEVivoryon Therapeutics N.V. Announces Virtual R&D Event with ..
15/9/202313:57GLOBEVivoryon Therapeutics N.V. Extraordinary General Meeting..
07/9/202307:00GLOBEVivoryon Therapeutics N.V. Reports H1 2023 Financial Results..
31/8/202307:00GLOBEVivoryon Therapeutics N.V. to Report Half Year 2023..
04/8/202323:35GLOBEVivoryon Therapeutics N.V. Extraordinary General Meeting to..
04/8/202323:30GLOBEVivoryon Therapeutics N.V. Announces Proposed Appointment of..
16/7/202309:00GLOBEVivoryon Therapeutics N.V. Shares Clinical Development..
21/6/202318:02GLOBEVivoryon Therapeutics N.V. Reports Outcome of 2023 Annual..
15/6/202317:49GLOBEVivoryon Therapeutics N.V. Announces CEO Transition Plan
01/6/202307:00GLOBEVivoryon Therapeutics N.V. to Participate in Upcoming..
26/5/202307:39GLOBEVivoryon Therapeutics Successfully Completes Private..
25/5/202317:50GLOBEVivoryon Therapeutics Launches Capital Increase by Way of an..
16/5/202307:00GLOBEVivoryon Therapeutics N.V. Reports Q1 2023 Financial Results..
09/5/202307:02GLOBEVivoryon Therapeutics N.V. to Hold its 2023 Annual General..
09/5/202307:00GLOBEVivoryon Therapeutics N.V. to Report Q1 2023 Financial..
01/5/202310:00GLOBEVivoryon Therapeutics N.V. Announces Planned Changes to..

Dernières Valeurs Consultées

Delayed Upgrade Clock